期刊文献+

高/低侵袭转移性肺癌干细胞模型的建立 被引量:1

Establishing High/Low Invasion Lung Tumor Stem Cells model
下载PDF
导出
摘要 目的以人肺癌NCI-H446细胞为研究对象,建立一种高/低侵袭性肺癌干细胞(high/low invasion lung tumor stemcells,H/L-ILTSCs)模型,并鉴定其生物学特性。方法首先,利用transwell小室迁移实验分离高/低迁移性NCI-H446细胞。取高/低迁移性NCI-H446细胞采用transwell小室侵袭实验分离高/低侵袭转移性NCI-H446细胞。然后,以CD133、CD44为肺癌干细胞(lung tumor stem cells,LTSCs)表面标志,采用磁珠分选法分离NCI-H446细胞H/L-ILTSCs并进行纯度鉴定。最后,采用MTT法、transwell侵袭及免疫缺陷动物成瘤等实验,检测H-ILTSCs、L-ILTSCs及NCI-H446细胞的生长增殖,体外侵袭转移及体内成瘤能力。结果 H-ILTSCs生长增殖,体外侵袭转移及体内成瘤能力均高于L-ILTSCs及NCI-H446细胞,而L-ILTSCs与NCI-H446无显著差别。结论人肺癌细胞NCI-H446中可以分离和富集H/L-ILTSCs,且二者存在着干性差别。 Objective To establish high/low invasion lung tumor stem cells (H/L - ILTSCs) model and to identify their biological propelties with human lung cancer cell line NCI - H446. Methods First, transwell immigration assay was used to separate high/low im- migration NCI - H446 cells. Then the high/low invasion NCI - H446 ceils were isolated from high/low immigration NCI - H446 cells by transwell invasion assay. Second, we used CD133 and CD44 as markers of human lung cancer stem cells (LTSCs) , separated H/L - ILTSCs by magnetic activated cell sorting and purity identification. Third, the growth and proliferation, tumor invasion in vitro and tumori- genicity potential and metastasis in viva were detected by MTT assay, transwell invasion assay, nude mouse transplanted tumor. Results The growth and proliferation, tumor invasion in vitro and tumorigenicity potential and metastasis in vivo of H - ILTSCs were higher than L - ILTSCs and normal NCI - H446 cells. But it had no difference between L - ILTSCs and normal NCI - H446 ceils. Conclusion H/L - ILTSCs could be isolated and expanded from human lung cancer cell line NCI - H446, and the both cells had different biological prop- erties.
出处 《医学研究杂志》 2012年第7期62-66,共5页 Journal of Medical Research
基金 浙江省自然科学基金资助项目(Y2101395) 浙江省舟山市卫生局基金资助项目(2010G02)
关键词 肺癌 NCI—H446细胞 侵袭转移性 肺癌干细胞 CD133 CD44 Lung cancer NCI - H446 cell line Invasion Lung Cancer stem ce11 CD133 CD44
  • 相关文献

参考文献15

  • 1中国疾病与癌症报告2010[EB/OL].http://oneotherapy.us/pdf/cn.diseases.pdf.
  • 2Juhan R, Ping Y, Stephen DC, et al. Non - Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship [J]. Mayo Clin Proc, 2008, 83 (5) :584 - 594.
  • 3Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bron- chioalveolar stem ceils in normal lung and lung cancer [ J]. Cell, 2005, 121(6) :823 -835.
  • 4Dalerba P, Cho RW, Clarke MF. Cancer stem cells:models and con- cepts [J]. AnnuRevMed, 2007, 58(1):267-284.
  • 5Wicha MS. Cancer stem cells and metastasis:lethal seeds [ J]. Clin Cancer Res, 2006, 12 (19) : 5606 - 5607.
  • 6Hermann PC. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer [ J]. Cell Stem Cell, 2007, 1(3) :313 -323.
  • 7林叔陈,张凤春,张雁云,徐迎春.乳腺癌干细胞的研究进展[J].肿瘤,2008,28(8):719-722. 被引量:7
  • 8Tie J, Pan YL, Zhao LN, et al. MiR -218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robol Receptor [ J ]. Plos Genetics, 2010, 6 (3) : e1000879.
  • 9Klein CA. Cancer: the metastasis cascade [ J ]. Science, 2008,321 (5897) :1785 - 1787.
  • 10Peter ME. Let - 7 and miR - 200 microRNAs : guardians against pluri- potency and cancer progression [ J ]. Cell Cycle, 2009,8 (6) : 843 - 852.

二级参考文献33

  • 1张玥,张凤春,张雁云.乳腺癌干细胞相关亚群细胞周期分析[J].肿瘤防治杂志,2005,12(24):1861-1864. 被引量:3
  • 2AL-HAJJ M, WICHA MS, BENITO-HERNANDEZ A, et al. Prospective identification of tumorigenic breast cancer cells[ J]. Proc Natl Acad Sci USA ,2003, 100( 7 ) :3983-3988.
  • 3KIM M, TURNQUIST H, JACKSON J, et al. The multidrug resistance transporter ABCG2 ( breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells[J]. Clin Cancer Res,2002, 8( 1 ) :22-28.
  • 4HENRICH CJ. BOKESCH HR, DEAN M, et al. A high-throughput cell-based assay for inhibitors of ABCG2 activity[ J ]. J Biomol Screen ,2006. 11 ( 2 ) : 176-183.
  • 5ZHENG X, SHEN G, YANG X, et al. Most C6 cells are cancer stem cells: evidence from clonal and population analyses [ J ]. Cancer Res .2007. 67 ( 8 ) :3691-3697.
  • 6XU J X, MORII E, LIU Y, et al. High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells: high expression of CD55 as a novel character for side-population[J]. Exp Cell Res . 2007 , 313(9) :1877-1885.
  • 7PHILLIPS T M, MCBRIDE W H, PAJONK F. The response of CD24^(-/low)/CD44^+ breast cancer-initiating cells to radiation [J]. J Natl Cancer Inst,2006, 98 ( 24 ) : 1777-1785.
  • 8PONTI D. COSTA A. ZAFFARONI N. et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties [ J ]. Cancer Res, 2005. 65 ( 13 ) : 5506-5511.
  • 9LIU BY, MCDERMOTT SP, KHWAJA SS, et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells[J]. Proc Natl Acad Sci USA,2004, 101(12) :4158-4163.
  • 10LINDVALL C, EVANS NC, ZYLSTRA CR, et al. The Wnt signaling receptor, LRP5, is required for mammary ductal stem cell activity and Wntl-induced tumorigenesis[J]. J Biol Chem,2006, 281 (46) :35081-35087.

共引文献6

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部